Hendrik-Tobias Arkenau
Fondatore presso Sarah Cannon Research Institute UK Ltd.
Profilo
Hendrik-Tobias Arkenau is the founder of Sarah Cannon Research Institute UK Ltd.
He held the title of Executive Medical Director since the company's founding in 1993.
Posizioni attive di Hendrik-Tobias Arkenau
| Società | Posizione | Inizio |
|---|---|---|
Sarah Cannon Research Institute UK Ltd.
 Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Fondatore | 01/01/1993 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Sarah Cannon Research Institute UK Ltd.
Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Commercial Services |
- Borsa valori
- Insiders
- Hendrik-Tobias Arkenau
